Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Ain Pharmaciez Inc (9627)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
5,952.0 -5.0    -0.08%
26/04 - Closed. Currency in JPY ( Disclaimer )
Type:  Equity
Market:  Japan
ISIN:  JP3105250009 
  • Volume: 319,300
  • Bid/Ask: 5,942.0 / 5,954.0
  • Day's Range: 5,878.0 - 6,030.0
Ain Pharmaciez Inc 5,952.0 -5.0 -0.08%

9627 Balance Sheet

 
Featured here, the Balance Sheet for Ain Pharmaciez Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2024
31/01
2023
31/10
2023
31/07
2023
30/04
Total Current Assets 106837 108214 101400 98305
Cash and Short Term Investments 50057 50518 47373 46796
Cash - - - -
Cash & Equivalents 50057 50280 47373 46796
Short Term Investments - 238 - 579
Total Receivables, Net - 29429 24644 25573
Accounts Receivables - Trade, Net 14006 13642 12718 13249
Total Inventory 27093 24855 24339 21585
Prepaid Expenses - - - -
Other Current Assets, Total 4019 3412 5044 4351
Total Assets 243688 242922 235647 231750
Property/Plant/Equipment, Total - Net 42745 40677 40113 39459
Property/Plant/Equipment, Total - Gross - - - 67298
Accumulated Depreciation, Total - - - -27840
Goodwill, Net 43947 44634 45611 46443
Intangibles, Net 6717 6342 6002 5900
Long Term Investments - 2900 36546 34947
Note Receivable - Long Term - 15554 11693 11969
Other Long Term Assets, Total 2 34109 1 2
Other Assets, Total 11874 5355 10946 7412
Total Current Liabilities 100847 102718 97840 92986
Accounts Payable 67987 66556 64859 58698
Payable/Accrued - - - -
Accrued Expenses - 3951 2382 3237
Notes Payable/Short Term Debt 3183 3643 3648 3670
Current Port. of LT Debt/Capital Leases - - - -
Other Current liabilities, Total 28107 28568 26951 27381
Total Liabilities 110412 113081 109032 105205
Total Long Term Debt 2366 2996 3848 5053
Long Term Debt 2366 2996 3848 5021
Capital Lease Obligations - - - 32
Deferred Income Tax - - - -
Minority Interest - 83 92 96
Other Liabilities, Total 3945 3641 -3892 -5291
Total Equity 133277 129841 126615 126545
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 21894 21894 21894 21894
Additional Paid-In Capital - 20499 20504 20504
Retained Earnings (Accumulated Deficit) 92586 89113 85996 85963
Treasury Stock - Common - -1983 -2000 -2000
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 281 318 221 184
Total Liabilities & Shareholders' Equity - 242922 235647 231750
Total Common Shares Outstanding 35.13 35.13 35.13 35.13
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

9627 Comments

Write your thoughts about Ain Pharmaciez Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email